Pharmaceutical Commerce - July/August 2013

Demonstration of second-generation IKnowMed EHR; over 90 studies involve US Oncology Network researchers

Merger combines Qforma's local analytics with SkilaMederi's national perspective

Using real-world databases for evidence development has strengths and weaknesses; with electronic health records (EHRs), new approaches are evolving

Group passes the initial ICANN evaluation; will NABP be the international policeman of online pharmacies?

Life sciences companies - including mid-market ones - are finding value in an outsourced service

The full range of healthcare manufacturers should have a unified voice

Disconnected business processes in contract administration, managed markets, rebates, sales compensation and related areas cause waste and inefficiency for company management

For global markets, there is a need to balance the imperative to get to market quickly against the evolving regulatory landscape

Attain Med, Inc., KeySource Medical, and Top Rx now represented in HDMA leadership

Upcoming California regulatory mandates, and the prospect of a national compliance requirement, are focusing industry attention. Here's what some industry leaders have to say

Following its pathbreaking alliance with Walgreens/Alliance Boots, AmerisourceBergen is busy executing its future plans

Given the profound changes in the pharmaceutical commercial model, sales and marketing must deliver integrated customer experiences across channels and adapt through real-time insights

Besides the ongoing debate over serialization, drug labels are playing a greater role in anti-counterfeiting, preventing medication errors and improving patient adherence

Given the profound changes in the pharmaceutical commercial model, sales and marketing must deliver integrated customer experiences across channels and adapt through real-time insights

Veeva and Cegedim roll out Windows 8 versions of their products

Cloud-based IT technologies are a natural fit for patient-support hubs